| Clinical and pathological characteristics | Variable |
| Age (years) |
|
| Range | 35 - 88 |
| Median | 66 |
| Gender |
|
| Male | 66 (66.1%) |
| Female | 42 (38.9%) |
| Tumor location |
|
| Cardia | 23 (21.3%) |
| Fundus | 6 (5.6%) |
| Lesser curvature | 20 (18.5%) |
| Greater curvature | 11 (10.2%) |
| Pylorus | 11 (10.2%) |
| >Localization | 37 (34.3%) |
| Invasion into adjacent organs |
|
| None | 77 (71.3%) |
| Liver | 8 (7.4%) |
| Pancreas | 12 (11.1%) |
| Spleen | 1 (0.9%) |
| Left diaphragm | 4 (3.7%) |
| Colon | 2 (1.9%) |
| >1 organ | 4 (3.7%) |
| Metastases |
|
| None | 67 (62%) |
| Liver | 10 (9.3%) |
| Carcinosis | 6 (5.6%) |
| Lymph node | 8 (7.4%) |
| Lungs, bones, mediastinum and etc. | 4 (3.7%) |
| >Localization | 13 (12%) |
| Depth of tumor invasion |
|
| Not determined | 8 (7.4%) |
| T1 | 3 (2.8%) |
| T2 | 13 (12%) |
| T3 | 52 (48.1%) |
| T4 | 32 (29.6%) |
| Lymph node metastasis |
|
| N0 | 39 (36.1%) |
| N1 | 31 (28.7%) |
| N2 | 26 (24.1%) |
| N3 | 12 (11.1%) |
| Distant metastasis |
|
| M0 | 66 (61.1%) |
| M1 | 42 (38.0%) |
| Surgery |
|
| Total gastrectomy | 24 (22.22%) |
| Subtotal gastrectomy | 40 (37.04%) |
| Inoperable tumor | 41 (37.96%) |
| Endoscopic mucosal resection | 3 (2.78%) |